Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Last Name

profileDaniel Eric Morganstern, M.D.

TitleInstructor in Medicine
InstitutionDana-Farber Cancer Institute
AddressDana Farber Cancer Institute
Dana 1210
44 Binney St
Boston MA 02115
vCardDownload vCard (login for email)

Collapse Bibliographic 
Collapse selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Moussawi K, Lin DJ, Matiello M, Chew S, Morganstern D, Vaitkevicius H. Brainstem and limbic encephalitis with paraneoplastic neuromyelitis optica. J Clin Neurosci. 2016 Jan; 23:159-61. PMID: 26412254.
    View in: PubMed
  2. Tolaney SM, Jeong J, Guo H, Brock J, Morganstern D, Come SE, Golshan M, Bellon J, Winer EP, Krop IE. A phase II study of preoperative capecitabine in women with operable hormone receptor positive breast cancer. Cancer Med. 2014 Apr; 3(2):293-9. PMID: 24464780; PMCID: PMC3987079.
  3. Nakabayashi M, Xie W, Buckle G, Bubley G, Ernstoff MS, Walsh W, Morganstern DE, Kantoff PW, Taplin ME. Long-term follow-up of a phase II trial of chemotherapy plus hormone therapy for biochemical relapse after definitive local therapy for prostate cancer. Urology. 2013 Mar; 81(3):611-6. PMID: 23452809.
    View in: PubMed
  4. Davis MP, Bruera E, Morganstern D. Early integration of palliative and supportive care in the cancer continuum: challenges and opportunities. Am Soc Clin Oncol Educ Book. 2013; 144-50. PMID: 23714482.
    View in: PubMed
  5. Lin NU, Kasparian E, Morganstern DE, Beard C. Geographic distribution of lapatinib-induced skin rash: sparing of abdominal skin persists in the transverse rectus abdominis myocutaneous flap. J Clin Oncol. 2009 Dec 1; 27(34):e218-9. PMID: 19786662.
    View in: PubMed
  6. Taplin ME, Xie W, Bubley GJ, Ernstoff MS, Walsh W, Morganstern DE, Regan MM. Docetaxel, estramustine, and 15-month androgen deprivation for men with prostate-specific antigen progression after definitive local therapy for prostate cancer. J Clin Oncol. 2006 Dec 1; 24(34):5408-13. PMID: 17135641.
    View in: PubMed
  7. Taplin ME, Bubley GJ, Rajeshkumar B, Shuster T, Ko YJ, Morganstern DE. Docetaxel, estramustine, and short-term androgen withdrawal for patients with biochemical failure after definitive local therapy for prostate cancer. Semin Oncol. 2001 Aug; 28(4 Suppl 15):32-9. PMID: 11685726.
    View in: PubMed
  8. Morganstern D, Garnick MB. Genitourinary cancers in older adults. Clin Geriatr Med. 1998 May; 14(2):333-65. PMID: 9536109.
    View in: PubMed
  9. Lichtman SM, Cirrincione CT, Hurria A, Jatoi A, Theodoulou M, Wolff AC, Gralow J, Morganstern DE, Magrinat G, Cohen HJ, Muss HB. Effect of Pretreatment Renal Function on Treatment and Clinical Outcomes in the Adjuvant Treatment of Older Women With Breast Cancer: Alliance A171201, an Ancillary Study of CALGB/CTSU 49907. J Clin Oncol. 2016 Mar 1; 34(7):699-705. PMID: 26755510.
    View in: PubMed
  10. Chott A, Sun Z, Morganstern D, Pan J, Li T, Susani M, Mosberger I, Upton MP, Bubley GJ, Balk SP. Tyrosine kinases expressed in vivo by human prostate cancer bone marrow metastases and loss of the type 1 insulin-like growth factor receptor. Am J Pathol. 1999 Oct; 155(4):1271-9. PMID: 10514409; PMCID: PMC1867033.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact For demographic and contact information changes only, HMS/HSDM faculty should contact Human Resources at
Morganstern's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
Co-Authors Expand Description
Similar People Expand Description
Same Department Expand Description
Physical Neighbors Expand Description